Skip to main content
SpringerLink
Log in

Rationnel du dépistage

  • Chapter
Le dépistage du cancer colorectal

Part of the book series: Dépistage et cancer ((DC))

  • 254 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Remontet L, Esteve J, Bouvier AM et al. (2003) Cancer incidence and mortality in France over the period 1978–2000. Rev Épidemiol Santé Publique 51: 3–30

    PubMed  CAS  Google Scholar 

  2. Bedenne L, Faivre J, Boutron MC et al. (1992) Adenoma-carcinoma sequence or “de novo” carcinogenesis? A study of adenomatous remnants in a populationbased series of large bowel cancers. Cancer 69: 883–8

    Article  PubMed  CAS  Google Scholar 

  3. Winawer SJ, Zauber AG, O’Brien MJ et al. (1993) Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328: 901–6

    Article  PubMed  CAS  Google Scholar 

  4. Jorgensen O, Kronborg O, Fenger C (1995) A randomized surveillance study of patients with pedunculated and small sessile tubular and tubulovillous adenomas. The Funen Adenoma follow-up study. Scand J Gastroenterol 30: 686–92

    PubMed  CAS  Google Scholar 

  5. Bretagne JF, Faivre J (2000) La Société Nationale Française de Gastroentérologie recommande la mise en place d’un dépistage généralisé et organisé du cancer colorectal en France. Gastroenterol Clin Biol 24: 492–3

    PubMed  CAS  Google Scholar 

  6. Conférence de consensus (1998) Prévention, dépistage et prise en charge des cancers du côlon. Gastroenterol Clin Biol 22: 205–26

    Google Scholar 

  7. Greegor DH (1967) Diagnosis of large-bowel cancer in the asymptomatic patient. Jama 201: 943–5

    Article  PubMed  CAS  Google Scholar 

  8. Young GP, St John DJ, Winawer SJ et al. (2002) Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97: 2499–507

    PubMed  Google Scholar 

  9. (2000) Recommendations on cancer screening in the European union. Advisory Committee on Cancer Prevention. Eur J Cancer 36: 1473–8

    Article  Google Scholar 

  10. Yamamoto M, Nakama H (2000) Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods. Hepatogastroenterology 47: 396–9

    PubMed  CAS  Google Scholar 

  11. Ransohoff DF, Lang CA (1997) Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med 126: 811–22

    PubMed  CAS  Google Scholar 

  12. Bertario L, Spinelli P, Gennari L et al. (1988) Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects. Dig Dis Sci 33: 609–13

    Article  PubMed  CAS  Google Scholar 

  13. Macrae FA, St John DJ (1982) Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 82: 891–8

    PubMed  CAS  Google Scholar 

  14. Launoy G, Smith TC, Duffy SW, Bouvier V (1997) Colorectal cancer mass-screening: estimation of fæcal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer 73: 220–4

    Article  PubMed  CAS  Google Scholar 

  15. Jouve JL, Remonte L, Dancourt V et al. (2001) Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening. Br J Cancer 84:1477–81

    Article  PubMed  CAS  Google Scholar 

  16. Gyrd-Hansen D, Sogaard J, Kronborg O (1997) Analysis of screening data: colorectal cancer. Int J Epidemiol 26: 1172–81

    Article  PubMed  CAS  Google Scholar 

  17. Lieberman DA, Weiss DG, Bond JH et al. (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343: 162–8

    Article  PubMed  CAS  Google Scholar 

  18. Mandel JS, Bond JH, Church TR et al. (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365–71

    Article  PubMed  CAS  Google Scholar 

  19. Pignone M, Campbell MK, Carr C et al. (2001) Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 4: 150–6

    PubMed  CAS  Google Scholar 

  20. Jaffe RM, Kasten B, Young DS et al. (1975) False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 83: 824–6

    PubMed  CAS  Google Scholar 

  21. Selby JV, Friedman GD, Quesenberry CP et al. (1993) Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med 118: 1–6

    PubMed  CAS  Google Scholar 

  22. Wahrendorf J, Robra BP, Wiebelt H et al. (1993) Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 2: 221–7

    PubMed  CAS  Google Scholar 

  23. Lazovich D, Weiss NS, Stevens NG et al. (1995) A case-control study to evaluate efficacy of screening for fæcal occult blood. J Med Screening 2: 84–89

    CAS  Google Scholar 

  24. Zappa M, Castiglione G, Grazzini G et al. (1997) Effect of fæcal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer 73: 208–10

    Article  PubMed  CAS  Google Scholar 

  25. Faivre J, Tazi MA, El Mrini T et al. (1999) Fæcal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Br J Cancer 79:680–3

    Article  PubMed  CAS  Google Scholar 

  26. Saito H, Soma Y, Koeda J et al. (1995) Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 61: 465–9

    PubMed  CAS  Google Scholar 

  27. Mandel JS, Church TR, Ederer F et al. (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91: 434–7

    Article  PubMed  CAS  Google Scholar 

  28. Kewenter J, Bjork S, Haglind E et al. (1988) Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 62: 645–51

    Article  PubMed  CAS  Google Scholar 

  29. Hardcastle JD, Chamberlain JO, Robinson MEH et al. (1996) Randomised controlled trial of fæcal-occult-blood screening for colorectal cancer. Lancet 348: 1472–77

    Article  PubMed  CAS  Google Scholar 

  30. Kronborg O, Fenger C, Olsen J et al. (1996) Randomised study of screening for colorectal cancer with fæcal-occult-blood test. Lancet 348: 1467–71

    Article  PubMed  CAS  Google Scholar 

  31. Faivre J, Dancourt V, Lejeune C et al. (2004) Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126: 1674–80

    Article  PubMed  Google Scholar 

  32. Scholefield JH, Moss S, Sufi F et al. (2002) Effect of fæcal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 50: 840–844

    Article  PubMed  CAS  Google Scholar 

  33. Jorgensen OD, Kronborg O, Fenger C (2002) A randomised study of screening for colorectal cancer using fæcal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 50: 29–32

    Article  PubMed  CAS  Google Scholar 

  34. Kronborg O, Jorgensen OD, Fenger C et al. (2004) Randomized study of biennial screening with a fæcal occult blood test: results after nine screening rounds. Scand J Gastroenterol 39: 846–51

    Article  PubMed  CAS  Google Scholar 

  35. Towler BP, Irwig L, Glasziou P et al. (2003) Screening for colorectal cancer using the fæcal occult blood test, Hemoccult (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update software

    Google Scholar 

  36. Towler B, Irwig L, Glasziou P et al. (1998) A systematic review of the effects of screening for colorectal cancer using the fæcal occult blood test, hemoccult. Br Med J 317: 559–65

    CAS  Google Scholar 

  37. Mandel JS, Church TR, Bond JH et al. (2000) The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer. N Engl J Med 343: 1603–7

    Article  PubMed  CAS  Google Scholar 

  38. Faivre J, Dancourt V (2002) Le dépistage du cancer colorectal. Certitudes et questions. Gastroenterol Clin Biol 26: B86–93

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’hépato-gastro-entérologie et oncologie digestive, CHU Ambroise-Paré, 9, avenue Charles-de-Gaulle, 92100, Boulogne, France

    É. Mitry

Authors
  1. É. Mitry
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Mitry, É. (2006). Rationnel du dépistage. In: Le dépistage du cancer colorectal. Dépistage et cancer. Springer, Paris. https://doi.org/10.1007/2-287-32803-3_1

Download citation

  • DOI: https://doi.org/10.1007/2-287-32803-3_1

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-32802-2

  • Online ISBN: 978-2-287-32803-9

Publish with us

Policies and ethics

Search

Navigation